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Although important gains have been made in child survival over the past two decades, 
reduction in neonatal mortality (ie, deaths in the first month of life) has lagged substantially. 
Neonatal deaths now account for 44% of all under-5 deaths worldwide.1 Preterm birth is the 
leading cause of neonatal death, the second leading cause of all under-5 mortality,2 and a 
leading cause of severe childhood neurological disability. Despite this high global burden, 
little is known about how to prevent preterm birth and, in low-income and middle-income 
countries, how best to scale up strategies that are practical and affordable.
Preterm birth is a final common pathway for many complex pathological processes. A 
comprehensive research agenda is therefore needed to accelerate identification of mediators 
of preterm birth and innovative solutions. To forge a road map for this action agenda, the 
Bill & Melinda Gates Foundation (BMGF), the Global Alliance to Prevent Prematurity and 
Stillbirth (GAPPS), March of Dimes (MOD), the Eunice Kennedy Shriver National Institute 
of Child Health and Human Development, and WHO convened meetings of experts to 
develop a research agenda that spans the range of discovery, development, and delivery 
science needed to drive global change. This Comment summarises this solution pathway 
(figure) and the next steps toward its implementation.
Growing political will and new technological opportunities make this an opportune time to 
reinvigorate a new initiative for preterm birth research. Multiple global initiatives have 
gained crucial momentum to address neonatal mortality and preterm birth, including the 
Millennium Development Goals, Every Woman Every Child, and the Every Newborn global 
action plan.3–6 An essential element of these efforts is the development of new solutions to 
achieve health targets. Scientific advancements in the past decade have created a new 
opportunity for transformative research into the complex biology of pregnancy, including 
computational biology, genomics, informatics, microbiology, immunology, social network 
analysis, cell biology, imaging, nanotechnologies, and implementation science.
The first element of a solution pathway for preterm birth is an understanding of the biology 
of pregnancy and novel targets for preterm prevention. Most cases of preterm birth are 
spontaneous or follow premature rupture of membranes, usually with no identifiable cause. 
Multiple factors are associated with preterm birth including family history, reproductive tract 
and remote site infections, inflammation, nutrition, race, poverty, and emotional and 
physical stress.7,8 Investigation of these interrelated factors and their biological networks 
leading to preterm birth will be needed to advance prevention.
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To understand how uterine and cervical tissues remain quiescent, sustain pregnancy, and 
later initiate contractility and remodelling, insights into molecular regulation of pregnancy 
are needed.9 Priorities include investigations of fetal–placental signalling of onset of labour 
and genomic, transcriptomic, proteomic, immunological, and metabolomic analyses.
The microbiome presents another important target for investigation. Female genital tract 
infections, altered microbiota, and associated inflammatory processes are strongly associated 
with preterm birth, particularly very preterm birth.10 Research is needed into microbial 
perturbations, immune responses, and interactions of microbiota with host and 
environmental factors. Investigations in low-income and middle-income countries are 
needed where microbial, host, and environmental milieux differ substantially.
The expansion of the application of genomics, transcriptomics, and related technologies 
offers new opportunities to identify genes, pathways, and associated factors that regulate 
parturition and their functions,11 including epigenetic and gene–environment investigations. 
Large-scale studies will be needed to address these complex investigations.
Rates of preterm birth and preterm-related mortality vary significantly by race, ethnic origin, 
and socioeconomic strata.7, 8 Biological mediators of disparities, however, remain largely 
unknown. Investigations into genetic, hormonal, microbial, inflammatory, nutritional, and 
environmental factors, and their interactions with social, emotional, physical, and 
environmental stressors will elucidate causality and identify strategies for prevention and 
care.
Prevention of preterm birth requires the early identification of women at risk. Accelerated 
application of novel methods, including systems biology and network analyses, will help to 
identify signals that drive parturition. Genetic, inflammatory, hormonal, and growth factors 
based on positive and negative feedback mechanisms can identify new biomarkers. Novel 
biotechnologies allow non-invasive monitoring of the maternal–fetal environment, by use of 
imaging, nanotechnology, and assessment of metabolic activity and signal cascades. 
Adaptations of existing technologies for low-income and middle-income countries are 
needed to improve assessment of gestational age, cervical length, and pregnancy monitoring.
The second element of a solution pathway for preterm birth is to improve the survival of 
preterm infants in low-income and middle-income countries. Practical solutions need to be 
developed and moved to scale to improve care. An expanded implementation science agenda 
will accelerate application of effective strategies at the community and facility level, 
including antenatal corticosteroids, newborn resuscitation, kangaroo mother care, nutrition, 
intrapartum monitoring, newborn skin emollients, chlorhexidine cord care, preconception 
care, and strengthened commodities and essential drug programmes.12 Adaptations of 
interventions for newborn care are needed, including simplified continuous positive airway 
pressure, ventilators, high-flow nasal cannulae, antibiotic regimens, and new surfactant 
formulations.
Intervention trials can assess efficacy and advance understanding of the biology of 
pregnancy in high-income and low-income settings. Examples include screening and 
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treatment of infectious and non-infectious proinflammatory processes and interventions that 
modulate immunological, microbial, and hormonal mediators.
The third element of the solution pathways is to improve the epidemiological data needed to 
track prevalence, risk factors, and programme effect. Accurate and standardised reporting of 
gestational age, preterm-related death, classification of preterm phenotypes, and health 
service coverage are needed in essential registries and surveys in all countries.
The final element of the solution pathway is to accelerate health gains by fostering 
innovation and collaboration. New approaches to research are needed that promote 
innovation and rapid translation of science to action. Transdisciplinary and multidimensional 
approaches are needed that examine interactions among complex biological mediators and 
health disparities. New models of funding can promote collaboration between investigators 
and across disciplines. Standardised databases and biorepositories will accelerate discovery, 
development, and delivery science.
The opportunity exists now to generate new knowledge and solutions that can move rapidly 
to health gains. To this end, BMGF, GAPPS, MOD, the US National Institutes of Health, 
and WHO have initiated efforts to forge a new coalition to advance the visibility and 
research needed to drive global change. The coalition is intended to be inclusive of other key 
stakeholders, inviting participation of governmental and multilateral organisations, 
foundations, and corporations that support research into maternal–newborn health and are 
committed to an accelerated agenda to reduce death and disability due to preterm birth. 
Finding solutions to the complex problem of preterm birth will not come easily, but will 
need an expanded strategic initiative. Time and again results have shown that investment in 
science yields health solutions. Now is a crucial time to effect such advancements for 
preterm birth.
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Figure. Summary of the preterm research solution pathway
The schematic summarises key elements of the solution pathway for preterm birth research, 
across the range of discovery, development, and delivery science. The agenda is global in its 
approach; strategies more relevant to high-income countries are in pink, and low-income and 
middle-income countries (LMIC) in grey. CPAP = continuous positive airway pressure. 
EmONC = emergency obstetric and newborn care. RMNCH = reproductive, maternal, 
newborn, and child health.
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